Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging

Teresa Marsden; Neil McCartan; Joanna Hadley; Steve Tuck; Louise Brown; Anna J Haire; Charlotte L Moss; Saran Green; Mieke Van Hemelrijck; Ton Coolen; Aida Santaolalla; Elizabeth Isaac; Giorgio Brembilla; Douglas Kopcke; Francesco Giganti; Harbir Sidhu; Shonit Punwani; Mark Emberton; Caroline M Moore; ReIMAGINE Study Group

doi:10.1016/j.euf.2021.03.027

Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging

Eur Urol Focus. 2021 May;7(3):503-505. doi: 10.1016/j.euf.2021.03.027. Epub 2021 Apr 23.

Authors

Teresa Marsden¹, Neil McCartan², Joanna Hadley², Steve Tuck³, Louise Brown⁴, Anna J Haire⁵, Charlotte L Moss⁵, Saran Green⁵, Mieke Van Hemelrijck⁵, Ton Coolen⁶, Aida Santaolalla⁷, Elizabeth Isaac⁸, Giorgio Brembilla⁸, Douglas Kopcke⁹, Francesco Giganti¹⁰, Harbir Sidhu⁸, Shonit Punwani⁸, Mark Emberton², Caroline M Moore²; ReIMAGINE Study Group

Affiliations

¹ UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: teresa.marsden@ucl.ac.uk.
² UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
³ ReIMAGINE Consortium Patient Representative.
⁴ MRC Clinical Trials Unit, University College London, London, UK.
⁵ Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
⁶ London Institute for Mathematical Sciences, London, UK.
⁷ Cancer Epidemiology Group, Division of Cancer Studies, King's College London School of Medicine, London, UK.
⁸ Centre for Medical Imaging, University College London, London, UK.
⁹ Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
¹⁰ UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.

Abstract

ReIMAGINE Screening is a single-centre study assessing the feasibility of biparametric magnetic resonance imaging as a screening tool for prostate cancer. The study outcomes will take us a step towards more accurate and less harmful prostate cancer screening.

Trial registration: ClinicalTrials.gov NCT04063566.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Early Detection of Cancer*
Humans
Magnetic Resonance Imaging / methods
Male
Prostate-Specific Antigen
Prostatic Neoplasms* / pathology

Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging

Authors

Affiliations

Abstract

Publication types

MeSH terms

Substances

Associated data

Grants and funding